Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | — | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
the infant did not experience any adverse issues or side effects from the administered vaccines; VAXELIS, VAXNEUVANCE, and ROTATRIX were all inadvertently administered to a 6-day-old infant; This spontaneous report was received from a physician and refers to a 6-day-old patient of unknown gender. The patient was a full-term baby (born at a gestation of 37 weeks). The patient's medical history or concomitant therapies were not reported. On 04-AUG-2025, the patient was inadvertently vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate [meningococcal protein conjugate] and hepatitis b [recombinant] vaccine (VAXELIS) suspension for injection, pneumococcal 15-valent conjugate vaccine (VAXNEUVANCE) suspension for injection and rotavirus vaccine live oral 1v (ROTARIX), administered for prophylaxis (dose, route of administration, anatomical location, lot # and expiration date were not reported) (Product administered to patient of inappropriate age). The patient did not experience any adverse issues or side effects from the administered vaccines and was otherwise doing well. Lot# is being requested and will be submitted if received.
Full term baby